PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact

LDL cholesterol goal: how low to go in very high-risk patients?

A new meta-analysis shows that very high-risk patients at or below goal gain additional benefit from further LDL cholesterol lowering. This poses key questions for guideline groups: How low should LDL cholesterol goal be set in very high-risk groups? And, how do clinicians identify patients who would benefit most? PCSK9 Forum Editor Professor John Chapman (UPMC-Sorbonne and Director Emeritus, INSERM, Paris, France), gives his view.

Read the report »

FOURIER update provides new impetus for guideline groups to reconsider LDL targets

Watch the video »

New slide deck: Inclisiran and the ORION clinical development programme

Download here »

Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Our popular therapeutic guide

Read online & download second edition now »

Register now at www.pcsk9forum.org to receive the updated third edition coming soon.
New eBook
Questions & Answers

Why are new treatments needed?


Read the full answer and other questions on the PCSK9 Forum »
Educational Partners
and Supporters
Amgen The Medicines Company Sanofi
Copyright PCSK9 Forum 2018. Please click here to unsubscribe from future mailings.
‚Äč